LEGISLATION: FEDERAL

To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

H.R.5382 — 116th Congress (2019-2020) · Rep. Fortenberry, Jeff [R-NE-1] · last updated
Latest Action: House — 12/11/2019 Referred to the Subcommittee on Health. (All Actions)